NCT07102459 - An Efficacy and Safety Study of LTG-001 Following Abdominoplasty | Biotech Hunter

Enrollment

360

Participants

Timeline

Start Date

July 24, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions

Acute PainPostoperative Pain Control

Interventions

DRUG

Experimental: LTG-001 High Dose

High Dose Active

DRUG

Experimental: LTG-001 Low Dose

Lower Dose Active

DRUG

Active Comparator: HB/APAP

Active Comparator

DRUG

Placebo Comparator

Placebo

Trial Locations (5)

RECRUITING

CenExel ACMR, Atlanta

RECRUITING

HD Research LLC, Houston

RECRUITING

Endeavor Clinical Research, San Antonio

RECRUITING

JBR Clinical Research (CenExel), Salt Lake City

RECRUITING

Arizona Research Center, Phoenix